{"key":"dulaglutide","slug":"dulaglutide","name":"Dulaglutide","other_names":[],"kind":"single","area":{"slug":"metabolic","name":"Metabolic"},"classification":"GLP-1 receptor agonist","standing":{"id":"approved","label":"Licensed medicine","rank":5},"summary":"A once-weekly GLP-1 receptor agonist, licensed for type 2 diabetes. Trials of newer agonists often use it as the active comparator.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":540,"in_humans":334,"clinical_trials":125},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/dulaglutide","article":null,"evidence":{"query":"(\"Dulaglutide\"[ti])","fetched_at":"2026-11-16T22:55:10.679Z","counts":{"rcts":115,"human":334,"total":540,"reviews":42,"clinicalTrials":125},"years":[{"year":2012,"count":4},{"year":2013,"count":0},{"year":2014,"count":13},{"year":2015,"count":28},{"year":2016,"count":31},{"year":2017,"count":22},{"year":2018,"count":41},{"year":2019,"count":52},{"year":2020,"count":50},{"year":2021,"count":49},{"year":2022,"count":54},{"year":2023,"count":64},{"year":2024,"count":65},{"year":2025,"count":70},{"year":2026,"count":59}],"top":[{"doi":"10.1016/S0140-6736(19)31149-3","url":"https://pubmed.ncbi.nlm.nih.gov/31189511/","kind":"rct","pmid":"31189511","year":2019,"title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","venue":"Lancet (London, England)","authors":"Gerstein HC, Colhoun HM, Dagenais GR, et al."},{"doi":"10.1056/NEJMoa2505928","url":"https://pubmed.ncbi.nlm.nih.gov/41406444/","kind":"trial","pmid":"41406444","year":2025,"title":"Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes","venue":"The New England journal of medicine","authors":"Nicholls SJ, Pavo I, Bhatt DL, et al."},{"doi":"10.1016/S2213-8587(18)30024-X","url":"https://pubmed.ncbi.nlm.nih.gov/29397376/","kind":"rct","pmid":"29397376","year":2018,"title":"Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial","venue":"The lancet. Diabetes & endocrinology","authors":"Pratley RE, Aroda VR, Lingvay I, et al."},{"doi":"10.3389/fphar.2025.1438318","url":"https://pubmed.ncbi.nlm.nih.gov/40444045/","kind":"review","pmid":"40444045","year":2025,"title":"Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis","venue":"Frontiers in pharmacology","authors":"Karimi MA, Gholami Chahkand MS, Dadkhah PA, et al."},{"doi":"10.1001/jamacardio.2026.0767","url":"https://pubmed.ncbi.nlm.nih.gov/41903177/","kind":"rct","pmid":"41903177","year":2026,"title":"Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial","venue":"JAMA cardiology","authors":"Nissen SE, Wolski K, D'Alessio D, et al."},{"doi":"10.1097/MJT.0000000000001743","url":"https://pubmed.ncbi.nlm.nih.gov/38976545/","kind":"meta","pmid":"38976545","year":2024,"title":"Comparative Meta-Analysis of Retatrutide Versus Placebo and Dulaglutide for Weight Loss and Diabetes Management: Insights From Clinical Trials","venue":"American journal of therapeutics","authors":"Ayesh H, Ayesh S, Niswender K"},{"doi":"10.1016/j.ahj.2023.09.007","url":"https://pubmed.ncbi.nlm.nih.gov/37758044/","kind":"trial","pmid":"37758044","year":2024,"title":"Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics","venue":"American heart journal","authors":"Nicholls SJ, Bhatt DL, Buse JB, et al."},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/30000038/","kind":"review","pmid":"30000038","year":2006,"title":"Dulaglutide","venue":"","authors":""},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/31643312/","kind":"review","pmid":"31643312","year":2012,"title":"Dulaglutide","venue":"","authors":""}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}